Brief: Rallybio Q4 Net Income USD -20.242 Million
12/03/2024 12:00
Mar 12 (Reuters) - Rallybio Q4 income from operations USD -21.112 million. * Q4 basic EPS USD -0.5 * Q4 operating expenses USD 21.112 million
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx